Compare BTMD & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTMD | DMA |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 76.4M |
| IPO Year | 2021 | 2011 |
| Metric | BTMD | DMA |
|---|---|---|
| Price | $1.72 | $8.24 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 140.8K | 42.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $197,191,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.37 | N/A |
| P/E Ratio | $2.50 | ★ N/A |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $1.70 | $7.17 |
| 52 Week High | $4.75 | $9.15 |
| Indicator | BTMD | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 24.94 | 37.70 |
| Support Level | N/A | N/A |
| Resistance Level | $2.20 | $8.87 |
| Average True Range (ATR) | 0.10 | 0.22 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 9.63 | 40.13 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.